Clinical Trial Update: 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over. [Phase 2]

View source ↗

Summary

A Phase 2 trial of trastuzumab and pertuzumab with hormonal therapy or chemotherapy in women aged 60 and over with metastatic breast cancer was terminated; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-05-27